SZodixStudyAcademic Library

Dashboard Shelves Open access My library Inbox Notes Write Learn Alerts

More

Ask your library Notifications Quick cite Review

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Maarten Jacobus Postma · Study

Home/Author

Maarten Jacobus Postma

31 works· latest 2024· 7 institutionscluster: provisionalORCID 0000-0002-6306-3653

h-index24

i1030

Citations2,395

Works here31

99

05

06

08

09

12

13

14

15

16

18

19

20

22

24

Most cited in this library

The burden of mental disorders, substance use disorders and self-harm among young people in Europe, 1990–2019: Findings from the Global Burden of Disease Study 20192022 · 347 citations
Need for differential discounting of costs and health effects in cost effectiveness analyses2005 · 225 citations
Dynamic Transmission Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-52012 · 223 citations
Dynamic Transmission Modeling2012 · 151 citations
A report on the status of vaccination in Europe2018 · 130 citations

Works

31 shown

Inter-reviewer reliability of human literature reviewing and implications for the introduction of machine-assisted systematic reviews: a mixed-methods review

BMJ Open·2024·9 authors·review·Open access

48citations

Vaccine hesitancy and equity: lessons learned from the past and how they affect the COVID-19 countermeasure in Indonesia

Globalization and Health·2024·4 authors·review·Open access

60citations

Estimates of the Global Burden of COVID-19 and the Value of Broad and Equitable Access to COVID-19 Vaccines

Vaccines·2022·10 authors·Open access

24citations

The burden of mental disorders, substance use disorders and self-harm among young people in Europe, 1990–2019: Findings from the Global Burden of Disease Study 2019

The Lancet Regional Health - Europe·2022·100 authors·Open access

347citations

Parents’ Knowledge, Attitude, and Practice on Childhood Vaccination During the COVID-19 Pandemic in Indonesia

Dove Medical Press (Taylor and Francis Group)·2022·5 authors

·Open access

27citations

The potential impact of COVID-19 pandemic on the immunization performance in Indonesia

Expert Review of Vaccines·2020·3 authors·editorial·Open access

55citations

Preventing infectious diseases for healthy ageing: The VITAL public-private partnership project

Vaccine·2020·8 authors·review·Open access

31citations

Factors associated with the uptake of newly introduced childhood vaccinations in Ethiopia: the cases of rotavirus and pneumococcal conjugate vaccines

BMC Public Health·2019·3 authors·Open access

25citations

Health-related quality of life in Indonesian type 2 diabetes mellitus outpatients measured with the Bahasa version of EQ-5D

Quality of Life Research·2019·9 authors·Open access

83citations

The Impact of Patent Expiry on Drug Prices: A Systematic Literature Review

Applied Health Economics and Health Policy·2018·4 authors·review·Open access

86citations

A report on the status of vaccination in Europe

Vaccine·2018·14 authors·review·Open access

130citations

Cost effectiveness of adding nucleic acid testing to hepatitis B , hepatitis C , and human immunodeficiency virus screening of blood donations in Z imbabwe

Transfusion·2016·8 authors

14citations

Economic Burden in Chinese Patients with Diabetes Mellitus Using Electronic Insurance Claims Data

PLoS ONE·2016·5 authors·Open access

50citations

Effect of vaccination programmes on mortality burden among children and young adults in the Netherlands during the 20th century: a historical analysis

The Lancet Infectious Diseases·2016·5 authors·Open access

95citations

The costs of producing a unit of blood in Z imbabwe

Transfusion·2015·11 authors·Open access

27citations

Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community

PharmacoEconomics·2015·20 authors·Open access

116citations

Namibia's transition from whole blood–derived pooled platelets to single‐donor apheresis platelet collections

Transfusion·2015·10 authors·Open access

10citations

Blood Component Use in a Sub-Saharan African Country: Results of a 4-Year Evaluation of Diagnoses Associated With Transfusion Orders in Namibia

Transfusion Medicine Reviews·2014·10 authors·Open access

29citations

Abstract Presentations from the AABB Annual Meeting Philadelphia, PA, October 25‐28, 2014

Transfusion·2014·2 authors·other

11citations

A Probabilistic Theory for Intertemporal Indifference

Theoretical Economics Letters·2014·2 authors·Open access

0citations

Human immunodeficiency virus prevalence, incidence, and residual transmission risk in first‐time and repeat blood donations in Z imbabwe: implications on blood safety

Transfusion·2013·6 authors·Open access

19citations

Dynamic Transmission Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-5

Value in Health·2012·7 authors·Open access

223citations

Dynamic Transmission Modeling

Medical Decision Making·2012·7 authors·Open access

151citations

Health economics of blood transfusion safety – focus on sub-Saharan Africa

Biologicals·2009·3 authors·review·Open access

28citations

Which factors are important in adults’ uptake of a (pre)pandemic influenza vaccine?

Vaccine·2009·9 authors

61citations

BLOOD DONORS AND BLOOD COLLECTION: Web interface–supported transmission risk assessment and cost‐effectiveness analysis of postdonation screening: a global model applied to Ghana, Thailand, and the Netherlands

Transfusion·2009·9 authors·Open access

31citations

Cost-Effectiveness of HIV Screening of Blood Donations in Accra (Ghana)

Value in Health·2008·10 authors·Open access

23citations

Discounting in economic evaluations: stepping forward towards optimal decision rules

Health Economics·2006·5 authors·Open access

107citations

Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: A pharmacoeconomic analysis linked to the prevention of renal and vascular endstage disease (PREVEND) study and the prevention of renal and vascular endstage disease intervention trial (PREVEND IT)

Clinical Therapeutics·2006·9 authors·Open access

129citations

Need for differential discounting of costs and health effects in cost effectiveness analyses

BMJ·2005·4 authors·Open access

225citations

Current and future medical costs of asthma and chronic obstructive pulmonary disease in the Netherlands

Respiratory Medicine·1999·6 authors·Open access

130citations